Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.8016 per EA under NDC 00054300001. Its NADAC has been published 221 times since Jun 1, 2022.
FDA first approved this application on Jan 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP
Butalbital, Acetaminophen, Caffeine and Codeine PhosphateStrength
325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054300001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA215138FDA Approved
1/26/2022
TE Code
AB
On Market Since
5/9/2022
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has been published 221 times since Jun 1, 2022, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8016 per EA |
|---|---|
| All-time high | $0.9542 (Feb 15, 2023) |
| All-time low | $0.5885 (Nov 20, 2024) |
| 52-week high | $0.9086 |
| 52-week low | $0.7990 |
| Median price | $0.8592 |
| Average price | $0.8469 |
| Largest weekly change | +43.5% (Jul 20, 2022) |
| Weeks tracked | 221 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.8016 per EA (NDC 00054300001), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has declined 6.7%. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
Since Jun 1, 2022, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has ranged from a low of $0.5885 (Nov 20, 2024) to a high of $0.9542 (Feb 15, 2023), with a median of $0.8592 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP (NDC 00054300001) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.